Insulin Pump Tandem denied for failing step therapy by Cigna?

Cigna's specific coverage criteria for insulin pump tandem are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Apply Step Therapy to a Tandem Insulin Pump

Step-therapy requirements for insulin pumps typically mean Cigna requires documented evidence that you have already used (or are currently using) multiple daily injections (MDI) of insulin — and that MDI has proven insufficient for adequate glycemic control — before it will authorize an insulin pump. This "try-and-fail" structure is common in commercial plans and reflects Cigna's view that an insulin pump is a second-line or advanced therapy rather than a first-line option. The denial may also arise because the documentation of prior therapy was not submitted with the original PA request or was considered insufficient.

## Why This Denial Is Appealable

Step-therapy denials are frequently overturned when the prescriber documents that (a) the prior therapy requirement has already been met, (b) prior therapy would be medically contraindicated or harmful, or (c) the patient's clinical situation makes skipping or abbreviating the step medically necessary. Many states also have step-therapy override laws that prohibit insurers from requiring step therapy when clinical contraindications exist — check whether your state's law applies to your plan type.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial notice. Request Cigna's step-therapy clinical criteria in writing so you can address each requirement specifically.
• External review: Under ACA §2719 and applicable state external review laws, you may request an IRO review within approximately four months of a final internal denial. External reviewers assess whether the step-therapy requirement is consistent with generally accepted clinical standards for your situation.
• Expedited review: If waiting to complete step-therapy requirements would pose a serious health risk — for example, if you have severe hypoglycemia unawareness or recurrent dangerous events on injections — document the urgency and request expedited review. Expedited decisions are typically required within 72 hours.

## Documentation to Gather

1. Prior therapy history with dates and outcomes: A detailed chronological list of every insulin regimen you have used — injection type, start and end dates, and the clinical outcome or reason for change. Lab results or CGM data from each period strengthen this record. 2. Evidence of inadequate control: Chart notes, HbA1c values over time, hypoglycemia logs, ER visits, or provider notes documenting that your current or prior injection regimen did not achieve adequate glycemic control. 3. Medical contraindication to continued step therapy (if applicable): If MDI is medically unsafe or contraindicated for you specifically, your prescriber must document this clearly and with clinical reasoning. 4. Prescriber medical-necessity letter: A letter from your endocrinologist or treating physician explaining why the Tandem pump is necessary and why the step-therapy requirement has been met or should be waived, referencing the applicable professional guideline organization (e.g., the applicable ADA/AACE guideline). 5. Cigna's step-therapy policy: Obtain the current published policy and map each stated requirement to your chart evidence one to one.

## Criteria-Mapping Structure

For each step Cigna requires, document the specific chart evidence showing it was completed or explain the clinical basis for an override. Organize your appeal response so that each of Cigna's requirements receives a direct, evidence-backed answer.